Dr. Mark Kirchhof
Dr. Mark Kirchhof is the Division Head of Dermatology in the Faculty of Medicine at the University of Ottawa and The Ottawa Hospital. After receiving his Bachelor of Science in molecular biology from McMaster University, Dr. Kirchhof completed his medical degree and PhD at Western University in London, Ontario. His PhD research involved studies of the signalling pathways important to immune system regulation. He then went on to complete his dermatology residency at the University of British Columbia in Vancouver, British Columbia.
Until August 2017, Dr. Kirchhof was the Education Director at Queen’s University in Kingston, Ontario, where he coordinated and led undergraduate, post-graduate and continuing medical education activities. He has published over 65 peer-reviewed papers and maintains a keen interest in clinical and bench-to-bedside research. He has been invited to speak at local, national and international meetings. His clinical interests are varied and he sees both pediatric and adult patients.
Real-world evidence for dupilumab in atopic dermatitis
Insights into long-term, real-world treatment patterns for AD provide valuable information on current clinical practice and may lead to improvements in clinical decision-making. This presentation will provide an overview of the real-world data on dupilumab’s efficacy and safety from various RWE sources, including registry data base on COVID-19 in AD patients.